Concordant with our RA findings, FCGR3A was associated with increased odds of BILAG MCR when analysed at the genotypic level, with FCGR3A-158V homozygotes demonstrating a 2.5-fold improved responses (p = 0.03). The gene discussed is FCGR3A; the disease is rheumatoid arthritis.